Show Summary Details
Page of

PTF1A: Pancreatic and Cerebellar Agenesis 

PTF1A: Pancreatic and Cerebellar Agenesis
PTF1A: Pancreatic and Cerebellar Agenesis

Jayne A. L. Houghton

and Andrew T. Hattersley

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 February 2021

Pancreatic and cerebellar agenesis is a discrete subgroup of patients who have permanent neonatal diabetes as a result of pancreatic agenesis. Patients with pancreatic and cerebellar agenesis present in the first week of life with diabetes requiring insulin treatment, very low birth weight, abnormal facies, and are subsequently detected as having pancreatic exocrine failure and pancreatic aplasia. Neurological features include central hypoventilation, optic nerve hypoplasia, developmental delay and cerebellar aplasia. This clinical syndrome results from homozygous mutations in the gene (PTF1A) encoding the Pancreatic Transcription Factor 1A. This confirms that in man, as in animal models, PTF1A has a critical role in early pancreatic and neurological development.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.